1. Hemostasis, thrombosis, fibrinolysis and cardiovascular disease;Weitz,2011
2. Walker EP. Panel recommends approval of rivaroxaban to prevent deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement: Medpage Today 2009.
3. FDA approval sought for rivaroxaban to prevent stroke in atrial fibrillation;Hurley;Neurol Today,2011
4. An update 12/9/2010: Dabigatran similar to warfarin in patients with history of stroke or transient ischemic attacks (TIA);Josephson,2010